A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving
Nanocarriers
Efflux
Penetration (warfare)
DOI:
10.1016/j.apsb.2021.04.021
Publication Date:
2021-05-07T16:49:08Z
AUTHORS (13)
ABSTRACT
Drug transportation is impeded by various barriers in the hypoxic solid tumor, resulting compromised anticancer efficacy. Herein, a lipid monostearin (MS)-coated CaO2/MnO2 nanocarrier was designed to optimize doxorubicin (DOX) comprehensively for chemotherapy enhancement. The MS shell of nanoparticles could be destroyed selectively highly-expressed lipase within cancer cells, exposing water-sensitive cores release DOX and produce O2. After cell death, core-exposed further liberated continue react with water tumor extracellular matrix (ECM) thoroughly O2 DOX, which exhibited cytotoxicity neighboring cells. Small molecules readily diffuse through ECM, collagen deposition decreased O2-mediated hypoxia-inducible factor-1 inhibition, leading synergistically improved drug penetration. Concurrently, DOX-efflux-associated P-glycoprotein also inhibited O2, prolonging retention Overall, transporting processes from deep cells including release, penetration, were optimized comprehensively, significantly boosted antitumor benefits.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....